Characteristics and Biomarkers of Ferroptosis.

Chen X, Comish PB, Tang D, Kang R. · 2021

Read Characteristics and Biomarkers of Ferroptosis. by Chen X, Comish PB, Tang D, Kang R. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7859349.txt.

Introduction

Chen and co-authors sum up the traits and markers of ferroptosis. Ferroptosis is cell death driven by iron overload and fat damage. It stands as a main route of tissue harm. Faulty control of it feeds many diseases. Brain decay, tumors, and infections all involve it.

The authors list what ferroptosis looks like in the lab and in tissue. Cell shape, size, and gene shifts all carry signs. Drugs that start or stop the process are catalogued. Spotting the process in real samples stays hard, though. Current markers lack sharpness and range. The review sets out what a good marker must do. That guide should help labs judge new claims.

Catalog record

CREATORChen X, Comish PB, Tang D, Kang R.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7859349

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Characteristics and Biomarkers of Ferroptosis By Xin Chen, Paul B Comish, Daolin Tang, Rui Kang Published in: Frontiers in Cell and Developmental Biology DOI: 10.3389/fcell.2021.637162 ABSTRACT Abstract The induction and consequences of regulated cell death (RCD) are accompanied by changes in gene and protein expression, biochemical pathways, as well as cell morphology and size. Such RCDs have a significant impact on development, tissue homeostasis, and the occurrence and progression of disease. Among different forms of RCD, ferroptosis appears to be the main cause of tissue damage driven by iron overload and lipid peroxidation. In fact, the dysfunctional ferroptotic response is implicated in a variety of pathological conditions and diseases, such as neurodegenerative diseases, tissue ischemia-reperfusion injury, tumorigenesis, infections, and immune diseases. Ferroptotic response can be fine-tuned through various oxidative stress and antioxidant defense pathways, coupling with metabolism, gene transcription, and protein degradation machinery. Accordingly, a series of ferroptosis inducers or inhibitors targeting redox- or iron metabolism-related proteins or signal transduction have been developed. Although this kind of RCD has recently attracted great interest in basic and clinical research, detecting and monitoring a ferroptotic response still faces challenges. In this mini-review, we not only summarize the latest knowledge about the characteristics of ferroptosis in vitro and in vivo, but also discuss the specificity and limitations of current biomarkers of ferroptosis. Keywords: ferroptosis, cell death, biomarker, lipid perioxidation, iron metabolism INTRODUCTION Cell death is a basic biological process that regulates cell fate, tissue regeneration, and the body’s immune response. Accidental cell death (ACD) and regulated cell death (RCD) are two major subcategories of cell death (Galluzzi et al., 2018). Unlike ACD, which is an uncontrolled rapid process, RCD usually utilizes clear molecular machinery involving multiple genes or proteins, and can be intervened on at multiple levels, especially using drugs or small molecular compounds (Tang et al., 2019). According to the publication record in PubMed,1 apoptosis, necroptosis, pyroptosis, and ferroptosis may be the most studied forms of RCD, involved in multiple pathological conditions and diseases. In some cases, several rare RCDs [e.g., alkaliptosis (Song et al., 2018b) and oxeiptosis (Holze et al., 2018)] have also been observed in cell cultures or mouse models, although their physiological or pathological significance remains largely unknown. Ferroptosis is a non-apoptotic and oxidative damage-related RCD (Dixon et al., 2012), mainly driven by iron accumulation, lipid peroxidation, and subsequent plasma membrane rupture (Tang and Kroemer, 2020). The process of ferroptosis is further controlled through a variety of molecular signaling achieved using epigenetic, transcription, and post-translational mechanisms (Chen et al., 2020b). After treatment with reagents or suffering environmental stresses, an increase in ferroptotic cell death can be observed in experimental models by activating the intrinsic or extrinsic pathways, which is discussed in depth in recent reviews (Chen et al., 2020b; Tang et al., 2020). Notably, two small molecular compounds, namely erastin (Dixon et al., 2012) and RSL3 (Yang et al., 2014), are the most commonly used reagents for triggering ferroptosis to study its molecular mechanisms. Excessive or deficient ferroptotic response also occurs in tissue samples of human diseases (Ashraf et al., 2020), which highlight the potential of pathological relevance of ferroptosis (Stockwell et al., 2017). In this min-review, we used some examples and their corresponding regulatory mechanisms to focus on the characteristics and biomarkers of ferroptosis (Figure 1). [Figure: Hallmarks of ferroptosis. Ferroptosis is a type of iron-dependent regulated cell death mainly caused by unrestricted lipid peroxidation and subsequent membrane damage. Ferroptotic cell death may show some morphological and biochemical characteristics as well as common changes in gene and protein levels. AA-COA, arachidonoyl-coenzyme A; ACSL4, acyl-CoA synthetase long-chain family member 4; ALOX, lipoxygenases; ARNTL, aryl hydrocarbon receptor nuclear translocator like; BH4, tetrahydrobiopterin; CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1; COQ10, Coenzyme Q10; ESCRT-III, endosomal sorting complex required for transport-III; GPX4, glutathione peroxidase 4; GSH, glutathione; HMGB1, high mobility group box 1; NFE2L2, nuclear factor erythroid 2-like 2; NOX, NADPH oxidases; POR, cytochrome P450 oxidoreductase; PTGS2, prostaglandin-endoperoxide synthase 2; PUFA, polyunsaturated fatty acids; SLC7A11, solute carrier family 7 member 11; TFRC, transferrin receptor; VDAC2/3, voltage dependent anion channel 2/3.] MORPHOLOGICAL HALLMARKS OF FERROPTOSIS What we call morphological features usually refers to cell changes observed through light or electron microscopy, and does not involve staining of special protein markers. Ferroptosis is generally a type of regulated necrosis, which is devoid of the morphological characteristics of apoptosis (e.g., cell shrinkage and plasma membrane blistering; Conrad et al., 2016). In contrast, necrotic morphology, such as cell enlargement and plasma membrane rupture, are commonly observed in most ferroptotic cells (Conrad et al., 2016). Consequently, the activation of cell membrane repair pathways, such as endosomal sorting complex required for transport-III (ESCRT-III) machinery, prevents ferroptotic cell death (Dai et al., 2020c). Electron microscopy shows that ferroptotic cells represent a vast change in mitochondrial ultrastructure, such as reduction in mitochondrial volume, increase in mitochondrial membrane density, and disappearance of mitochondrial cristae (Yagoda et al., 2007; Dixon et al., 2012). Since elevated autophagy promotes ferroptosis (Liu J. et al., 2020), autophagy-related ultrastructures (e.g., double-membrane autophagosomes and various lysosome-related vesicles) are often observed in ferroptotic cells or tissues (Friedmann Angeli et al., 2014). Although activators of ferroptosis lead to oxidative damage in DNA (Song et al., 2016), the nucleus of ferroptotic cells seem to be normal and lack chromatin concentration (Yagoda et al., 2007), which is a morphological marker of apoptotic cells. As a type of inflammatory RCD, immune cell infiltration is observed in tissues affected by the ferroptotic damage. For example, acute pancreatitis is a sterile inflammatory disease caused by the death of acinar cells. Ferroptotic acinar death contributes to experimental pancreatitis in mice, especially in cases of impaired circadian rhythms (Liu et al., 2020b). This ferroptosis-related pancreatitis is associated with pancreatic histological damage and leukocyte infiltration that can be detected using hematoxylin and eosin stain (Liu et al., 2020b). In general, the necrotic morphology caused by ferroptosis has been observed in vitro or in tissues, but it is difficult to distinguish ferroptosis from other types of regulated necrosis based on these changes alone. BIOCHEMICAL HALLMARKS OF FERROPTOSIS Accumulation of Cellular Iron Since the initial study defined ferroptosis as an iron-dependent RCD, iron accumulation-mediated biochemical events (e.g., elevated Fenton reaction or activated iron-containing enzymes) seem to be a biochemical sign of ferroptosis (Chen et al., 2020c). Iron is an essential trace element, distributed in various subcellular organelles (e.g., mitochondria and lysosomes). The level of intracellular or mitochondrial ferrous iron (Fe2+) is increased in ferroptotic cells or tissues, which can be monitored by a biochemical assay kit (Yuan et al., 2016a), Prussian blue staining (Lu et al., 2020), or probes [e.g., FerroFarRed (Homma et al., 2020) or Phen Green SK (Song et al., 2018a)]. In contrast, iron chelators (e.g., deferoxamine) limit ferroptosis in vitro (Dixon et al., 2012) or in vivo (Lu et al., 2020). The level of iron in cells is controlled by a complex network that involves the absorption, storage, utilization, and outflow of iron (Chen et al., 2020c). As expected, certain molecular regulators related to iron homeostasis control ferroptosis sensitivity. For example, iron uptake mediated by transferrin (TF; Gao et al., 2015), lactotransferrin (LTF; Wang et al., 2020), and transferrin receptor (TFRC; Gao et al., 2015), as well

Read the complete text